Alireza Afshari-Safavi

Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis

V. Shaygannejad, E. Sadeghi, A. Zabeti, 2022, Multiple sclerosis international.

Assessment of intelligence quotient in patients with neuromyelitis optica spectrum disease and multiple sclerosis.

V. Shaygannejad, F. Ashtari, M. Barekatain, 2022, Multiple sclerosis and related disorders.

Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis

V. Shaygannejad, Geir Bjorklund, A. Afshari-Safavi, 2021, Dysphagia.

Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis

V. Shaygannejad, S. Brand, D. Sadeghi Bahmani, 2020, Journal of clinical medicine.

Higher Disease and Pain Severity and Fatigue and Lower Balance Skills Are Associated with Higher Prevalence of Falling among Individuals with the Inflammatory Disease of Neuromyelitis Optica Spectrum Disorder (NMOSD)

R. Motl, V. Shaygannejad, S. Brand, 2020, Journal of clinical medicine.

Worldwide prevalence of neuromyelitis optica spectrum disorder (NMOSD) and neuromyelitis optica (NMO): a systematic review and meta-analysis

V. Shaygannejad, A. Zabeti, M. Kiani, 2023, Neurological Sciences.

Incidence, prevalence, and characteristics of heart failure among patients with multiple sclerosis: A systematic review and meta-analysis.

V. Shaygannejad, A. Afshari-Safavi, S. Bagherieh, 2022, Multiple sclerosis and related disorders.

Effectiveness of Schema Therapy on Anxiety, Depression, Fatigue, Quality of Life, and Sleep in Patients with Multiple Sclerosis: A Randomized Controlled Trial

V. Shaygannejad, A. Afshari-Safavi, O. Mirmosayyeb, 2023, Middle East Journal of Rehabilitation and Health Studies.

COVID-19 Among Patients With Multiple Sclerosis

V. Shaygannejad, A. Maghzi, A. Afshari-Safavi, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Comparing the consequences of COVID-19 vaccination between central nervous system (CNS) demyelinating diseases and other neurological disorders

V. Shaygannejad, Narges Ebrahimi, O. Mirmosayyeb, 2024, Vaccine.